Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients

Biomed Pharmacother. 2009 Dec;63(10):707-9. doi: 10.1016/j.biopha.2008.08.011. Epub 2008 Sep 16.

Abstract

We report on acute painful neuropathy following reduction of high serum glucose levels in six diabetic patients, aged 27-52 (5 males). Initial glucose levels ranging between 270 and 600 mg/dL decreased to 60-160 mg/dL following insulin, pharmacologic or dietary treatment. Four patients had long-standing untreated diabetes (3-5 years). All six patients experienced severe excruciating neuropathic pain 2-4 weeks after initiation of treatment. Pain was generalized in all, starting in the feet in 4 cases. Pain intensity prompted the use of combination therapy with various anti-neuropathic pain agents. Symptoms gradually improved in all patients, allowing discontinuation of symptomatic therapy within 3-8 months. We conclude that acute painful neuropathy can complicate the correction of high glucose levels in diabetic patients. Therefore, careful correction of glucose levels should be considered in patients with long-standing uncontrolled diabetes.

MeSH terms

  • Acute Disease
  • Adult
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism*
  • Diabetes Mellitus / diet therapy
  • Diabetes Mellitus / drug therapy
  • Diabetic Neuropathies / drug therapy
  • Diabetic Neuropathies / etiology*
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Insulin / adverse effects
  • Insulin / therapeutic use
  • Male
  • Middle Aged
  • Severity of Illness Index

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin